E. Milozzi

Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents

E. Nicastri, A. Antinori, P. Piselli, 2023 .

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

A. d’Arminio Monforte, C. Agrati, E. Nicastri, 2023, eClinicalMedicine.

Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers

G. D'offizi, C. Agrati, E. Cimini, 2021, Biology of Sex Differences.

Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study

V. Puro, C. Taibi, R. Lionetti, 2023, Biomedicines.

Evolution of SARS‐CoV‐2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID‐19 in an Italian reference hospital: Impact on clinical outcomes

E. Nicastri, A. Antinori, P. Piselli, 2023, Journal of medical virology.

Initial antifungal strategy does not correlate with mortality in patients with candidemia

B. Posteraro, G. Scoppettuolo, R. Murri, 2016, European Journal of Clinical Microbiology & Infectious Diseases.